Company Analysis

Cryo-Cell International Inc. (CCEL)

NYSE: CCEL · Services-Misc Health & Allied Services, NEC · Oldsmar, FL · filing with the SEC since 1997
Grade4.5
◀ Past 3.8● Present 5.0▶ Future 4.5

The company now

Cryo-Cell International Inc. is classed by the SEC under Services-Misc Health & Allied Services, NEC (industry code 8090), based in Oldsmar, FL. In its latest annual figures on file, for the fiscal year ended 2025-11-30, it reported revenue of $32 million and a loss of $2.4 million (its filed statements).

From its filings and filed figures; the desk's account of it is not written yet.

Where the revenue comes from

fiscal 2025, as filed

Revenue by line of business, fiscal 2025

Line of businessFiscal 2025Fiscal 2024Share of revenue
Umbilical Cord Blood and Cord Tissue Stem Cell Service$31.4M$31.6M99.4%
Public Cord Blood Banking$129,513$366,672under 1%
Prepacytecb$54,104$67,884under 1%

As tagged in its annual report (Form 10-K, filed Feb 27, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.

The desk's written account of this company, its Past, Present and Future, is not on file yet.

How the company works

The desk has not read this company's annual report yet.

The record in brief

The desk has not written this company's report yet.

SI Assistanton CCEL · research, not advice